EGF and prostate carcinoma: The results indicate several interactions for VEGFA, EGF, EGFR, IL1B, CXCL8, IL6, MTOR, AKT1, MMP9, and FN1, which are known to be involved in gravisensing of PC-3 prostate cancer cells exposed to short-term r-μg (Figure 8C).